Cancer clinical trials in the region Grand Est
156 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT05296798
HER2 Positive
HR Positive
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 4 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05514054
HER2 Negative
HR Positive
Localized
Hormone therapy
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique de Blois (La Chaussée-Saint-Victor), Groupe Hospitalier La Rochelle-Ré-Aunis (La Rochelle), Clinique Chénieux (Limoges) (and 31 more...)
Eli Lilly et compagnie
Phase 3
Lung cancer
#NCT04790253
SCLC (Small Cell Lung Cancer)
Chemotherapy
Chemotherapy
Centre Henri Becquerel (Rouen ), Institut Bergonié (Bordeaux), Gustave Roussy (Villejuif), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite) (and 7 more...)
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3
Lung cancer
#NCT06151574
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
HER2
Systemic Treatment-Naive
CHU de Rennes - Hôpital Pontchaillou (Rennes), Hôpital Tenon AP-HP (Paris ), Institut Curie - Paris (Paris), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Léon Bérard (Lyon) (and 1 more...)
Boehringer Ingelheim
Phase 3
Breast cancer
#NCT05382286
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ) (and 9 more...)
Gilead Sciences
Phase 3
Lymphoma
#NCT05371093
B cell lymphoma
Follicular lymphoma
None
Chemotherapy
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
Car-T
Centre Henri Becquerel (Rouen ), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Henri-Mondor AP-HP (Créteil), Institut Paoli-Calmettes (Marseille) (and 6 more...)
Kite, A Gilead Company
Phase 3
Lung cancer
#NCT05211895
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Chemotherapy
Radiotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
ALK
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier François Mitterrand de Pau (Pau), Centre Hospitalier de Cornouaille (Quimper), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire), Centre Hospitalier de Saint Quentin (Saint-Quentin) (and 7 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT05774951
HER2 Negative
HR Positive
Localized
Surgery
Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier d'Argenteuil (Argenteuil), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Groupe Hospitalier Saint André (Bordeaux) (and 20 more...)
AstraZeneca
Phase 3
Prostate cancer
#NCT04916613
Metastatic Hormone-sensitive
Systemic Treatment-Naive
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Institut Bergonié (Bordeaux), CHP Brest - Pasteur Vivalto Santé (Brest) (and 35 more...)
UNICANCER
Phase 3
Prostate cancer
#NCT04691804
Adenocarcinoma
Metastatic Castration-resistant
Hormone therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre Eugene Marquis (Rennes), Hôpital Européen Georges Pompidou - AP-HP (Paris), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon), Hôpital Claude Huriez (Lille) (and 3 more...)
Jiangsu HengRui Medicine Co., Ltd